BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9259413)

  • 1. Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells.
    Dorssers LC; Veldscholte J
    Int J Cancer; 1997 Aug; 72(4):700-5. PubMed ID: 9259413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site.
    Dorssers LC; van Agthoven T; Dekker A; van Agthoven TL; Kok EM
    Mol Endocrinol; 1993 Jul; 7(7):870-8. PubMed ID: 8413311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells.
    van Agthoven T; van Agthoven TL; Dekker A; van der Spek PJ; Vreede L; Dorssers LC
    EMBO J; 1998 May; 17(10):2799-808. PubMed ID: 9582273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.
    Brinkman A; van der Flier S; Kok EM; Dorssers LC
    J Natl Cancer Inst; 2000 Jan; 92(2):112-20. PubMed ID: 10639512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional identification of genes causing estrogen independence of human breast cancer cells.
    van Agthoven T; Veldscholte J; Smid M; van Agthoven TL; Vreede L; Broertjes M; de Vries I; de Jong D; Sarwari R; Dorssers LC
    Breast Cancer Res Treat; 2009 Mar; 114(1):23-30. PubMed ID: 18351453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response.
    van Agthoven T; Sieuwerts AM; Meijer D; Meijer-van Gelder ME; van Agthoven TL; Sarwari R; Sleijfer S; Foekens JA; Dorssers LC
    Endocr Relat Cancer; 2010 Mar; 17(1):215-30. PubMed ID: 19966015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells.
    Meijer D; van Agthoven T; Bosma PT; Nooter K; Dorssers LC
    Mol Cancer Res; 2006 Jun; 4(6):379-86. PubMed ID: 16778085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic mechanisms of estrogen-independence in breast cancer.
    Dorssers LC; van Agthoven T
    Pathol Res Pract; 1996 Jul; 192(7):743-51. PubMed ID: 8880875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
    van Agthoven T; Sieuwerts AM; Veldscholte J; Meijer-van Gelder ME; Smid M; Brinkman A; den Dekker AT; Leroy IM; van Ijcken WF; Sleijfer S; Foekens JA; Dorssers LC
    Br J Cancer; 2009 Dec; 101(11):1824-32. PubMed ID: 19904269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
    Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
    Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR-75-1 human breast cancer cells in vitro and in nude mice.
    Wärri AM; Laine AM; Majasuo KE; Alitalo KK; Härkönen PL
    Int J Cancer; 1991 Oct; 49(4):616-23. PubMed ID: 1680817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells.
    Thrane S; Pedersen AM; Thomsen MB; Kirkegaard T; Rasmussen BB; Duun-Henriksen AK; Lænkholm AV; Bak M; Lykkesfeldt AE; Yde CW
    Oncogene; 2015 Aug; 34(32):4199-210. PubMed ID: 25362855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
    Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.
    Zhou Y; Yau C; Gray JW; Chew K; Dairkee SH; Moore DH; Eppenberger U; Eppenberger-Castori S; Benz CC
    BMC Cancer; 2007 Apr; 7():59. PubMed ID: 17407600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of acquired antiestrogen resistance and its management in breast cancer].
    Iino Y; Maemura M; Morishita Y
    Nihon Rinsho; 1997 May; 55(5):1149-54. PubMed ID: 9155167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen resistance in breast cancer: elucidating mechanisms.
    Dorssers LC; Van der Flier S; Brinkman A; van Agthoven T; Veldscholte J; Berns EM; Klijn JG; Beex LV; Foekens JA
    Drugs; 2001; 61(12):1721-33. PubMed ID: 11693462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells.
    Zhou Q; Zeng H; Ye P; Shi Y; Guo J; Long X
    Anticancer Drugs; 2018 Jul; 29(6):539-548. PubMed ID: 29557813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.